This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights Cisco Systems, NextEra Energy, Moody's, PayPal and Keurig Dr Pepper
by Zacks Equity Research
Cisco Systems, NextEra Energy, Moody's, PayPal and Keurig Dr Pepper are part of the Zacks top Analyst Blog.
Top Analyst Reports for Cisco Systems, NextEra Energy & Moody's
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems, Inc. (CSCO), NextEra Energy, Inc. (NEE) and Moody's Corporation (MCO).
Keurig (KDP) Q2 Earnings Meet Estimates, Volumes Drive Sales
by Zacks Equity Research
Keurig's (KDP) second-quarter 2024 results reflect impressive net sales trends, considerable margin growth and solid earnings improvement.
Keurig Dr Pepper (KDP) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Keurig Dr Pepper (KDP) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Keurig Dr Pepper, Inc (KDP) Q2 Earnings Match Estimates
by Zacks Equity Research
Keurig Dr Pepper (KDP) delivered earnings and revenue surprises of 0% and 0.54%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Keurig Dr Pepper (KDP) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Keurig Dr Pepper's (KDP) second-quarter 2024 results are likely to reflect gains from brand strength and pricing actions. However, a sluggish Coffee unit is a concern.
Investing in Coca-Cola (KO) Before Q2 Earnings: Smart Move?
by Rajani Lohia
A robust brand portfolio, strategic investments and growth across segments are likely to have aided Coca-Cola's (KO) Q2 sales and volumes. Inflationary pressures and currency woes may dampen results.
Keurig Dr Pepper, Inc (KDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Keurig Dr Pepper (KDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPS
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Eaton, Palo Alto, Keurig Dr Pepper and Yum! Brands
by Zacks Equity Research
Thermo Fisher Scientific, Eaton, Palo Alto, Keurig Dr Pepper and Yum! Brands are included in this Analyst Blog.
Top Analyst Reports for Thermo Fisher, Eaton & Palo Alto
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), Eaton Corporation plc (ETN) and Palo Alto Networks, Inc. (PANW).
Keurig Dr Pepper's (KDP) Brands & Pricing Aid: Apt to Hold?
by Zacks Equity Research
Keurig Dr Pepper (KDP) gains from brand strength, significant pricing actions and a solid performance in its Refreshment Beverages segment.
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?
by Zacks Equity Research
Sector ETF report for RSPS
Pre-Q2 Earnings Review: To Buy or Not to Buy PepsiCo (PEP)?
by Rajani Lohia
A strong beverage unit and its international units' momentum to aid PepsiCo's (PEP) Q2 results. However, recall-related woes are likely to have hurt. We assess if the stock is a good buy before Q2.
Constellation Brands (STZ) Rises on Q1 Earnings Beat, Solid View
by Zacks Equity Research
Constellation Brands' (STZ) Q1 results reflect continued volume growth in the beer business and gains from improved operating margin expansion.
Can Molson Coors' (TAP) Revitalization Plan Aid Amid Cost Woes?
by Zacks Equity Research
Molson Coors' (TAP) Revitalization plan, premiumization efforts and cost-saving plan place it well for long-term growth amid rising costs due to inflationary woes.
Is Keurig Dr Pepper (KDP) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Keurig Dr Pepper, Inc (KDP) and Premier Foods PLC. (PRRFY) have performed compared to their sector so far this year.
Keurig Dr Pepper's (KDP) Strategic Initiatives Look Encouraging
by Zacks Equity Research
Keurig Dr Pepper (KDP) gains from brand strength, significant pricing actions and solid performance in its Refreshment Beverages segment.
Keurig Dr Pepper (KDP) Agrees to Acquire Kalil Bottling Assets
by Zacks Equity Research
Keurig Dr Pepper (KDP) is gaining from brand strength, significant pricing actions and a solid performance in its cold beverages.
Coca-Cola (KO) Down 0.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Coca-Cola (KO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Keurig Dr Pepper's (KDP) Strategic Efforts Good: Apt to Hold
by Zacks Equity Research
Keurig Dr Pepper's results reflect gains from brand strength, significant pricing actions and a solid performance in its cold beverages.
Molson Coors (TAP) to Post Q1 Earnings: Brand Strength to Aid
by Zacks Equity Research
Molson Coors' (TAP) Q1 earnings results are likely to reflect gains from strategic premiumization, targeted brand investments and efficient cost management.
Keurig (KDP) Stock Gains as Q1 Earnings & Sales Top Estimates
by Zacks Equity Research
Keurig's (KDP) Q1 results reflect strong brand momentum, as evident from market share growth across regions and elasticity across most categories. Improved net price realization also aids results.
Compared to Estimates, Keurig Dr Pepper (KDP) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Keurig Dr Pepper (KDP) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Coca-Cola (KO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Coke (KO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.